Related references
Note: Only part of the references are listed.FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine
Da Li et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2007)
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis
A Akinc et al.
JOURNAL OF GENE MEDICINE (2005)
Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival
P Erbacher et al.
JOURNAL OF DRUG TARGETING (2004)
PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles
S Mishra et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2004)
Gene transfer with modified polyethylenimines
A Kichler
JOURNAL OF GENE MEDICINE (2004)
Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system
C Burger et al.
MOLECULAR THERAPY (2004)
A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin
I Kopatz et al.
JOURNAL OF GENE MEDICINE (2004)
Strategies to improve DNA polyplexes for in vivo gene transfer: Will artificial viruses be the answer?
E Wagner
PHARMACEUTICAL RESEARCH (2004)
Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone
W Zheng et al.
DEVELOPMENTAL NEUROSCIENCE (2004)
Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer
S Boeckle et al.
JOURNAL OF GENE MEDICINE (2004)
Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes
M Ogris et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord
L Shi et al.
GENE THERAPY (2003)
Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates
J Lanciotti et al.
MOLECULAR THERAPY (2003)
Integrin targeting using RGD-PEI conjugates for in vitro gene transfer
K Kunath et al.
JOURNAL OF GENE MEDICINE (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations
F Ungaro et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity
R Kircheis et al.
CANCER GENE THERAPY (2002)
Polyethylenimine-graft-poly(ethylene glycol) copolymers:: Influence of copolymer block structure on DNA complexation and biological activities as gene delivery system
H Petersen et al.
BIOCONJUGATE CHEMISTRY (2002)
Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain
RL Klein et al.
EXPERIMENTAL NEUROLOGY (2002)
Identification of FGF receptor-binding peptides for cancer gene therapy
F Maruta et al.
CANCER GENE THERAPY (2002)
The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-κB decoy in mice
K Kunath et al.
PHARMACEUTICAL RESEARCH (2002)
Different strategies for formation of PEGylated EGF-conjugated PEI/DNA complexes for targeted gene delivery
T Blessing et al.
BIOCONJUGATE CHEMISTRY (2001)
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
KD Fisher et al.
GENE THERAPY (2001)
FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de Novo tissue formation
LA Chandler et al.
MOLECULAR THERAPY (2000)
Cationic polymer based gene delivery systems
SC De Smedt et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
